Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1038795Generated: October 31, 2026

Tert-butyl (piperidin-4-ylmethyl)carbamate → Tert-butyl (1-(2-chlorofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate

https://huagongshe.com/reaction/1038795

Reaction equation

Participants

RoleNameHCIDCharge
ReactantTert-butyl (piperidin-4-ylmethyl)carbamateHCID 723429—
Reactant2,4-Dichlorofuro[3,2-D]pyrimidineHCID 45789968—
ReactantTert-butyl(1-(2-(4-sulfamoylphenylamino)furo[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamateHCID 70143000—
ProductTert-butyl (1-(2-chlorofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamateHCID 86665090—

Reaction Steps

The precursor to Example #C.1, tert-butyl (1-(2-(4-sulfamoylphenylamino)furo[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate, was prepared as shown in Scheme B. 2,4-Dichlorofuro[3,2-d]pyrimidine [Ark Pharm] and tert-butyl piperidin-4-ylmethylcarbamate [Astatech] are reacted following conditions given in General Procedure A to give tert-butyl (1-(2-chlorofuro[3,2-d]pyrimidin-4-yl)piperidin-4-yl)methylcarbamate. The intermediate is then reacted with 4-aminobenzenesulfonamide using the conditions described in General Procedure B to give the precursor to Example #C.1. The reaction sequence detailed above is translated in the preparations and examples section to “prepared using A from 2,4-dichlorofuro[3,2-d]pyrimidine [ArkPharm] with tert-butyl piperidin-4-ylmethylcarbamate [Astatech] and B with 4-aminobenzenesulfonamide.”

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08551981B2
Source datasetuspto-grants-2013_10
ORD IDord-d6c016dc052f4821b828c589137ce415
Source noteuspto-grants-2013_10